BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8393604)

  • 1. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.
    Rosen E; Stapleton JT; McLinden J
    Vaccine; 1993; 11(7):706-12. PubMed ID: 8393604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles.
    Winokur PL; McLinden JH; Stapleton JT
    J Virol; 1991 Sep; 65(9):5029-36. PubMed ID: 1651421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection.
    Jia XY; Summers DF; Ehrenfeld E
    J Infect Dis; 1992 Feb; 165(2):273-80. PubMed ID: 1309847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.
    Stapleton JT; Raina V; Winokur PL; Walters K; Klinzman D; Rosen E; McLinden JH
    J Virol; 1993 Feb; 67(2):1080-5. PubMed ID: 7678298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.
    Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F
    J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses.
    Hughes JV; Stanton LW
    J Virol; 1985 Aug; 55(2):395-401. PubMed ID: 2991564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.
    LaBrecque FD; LaBrecque DR; Klinzman D; Perlman S; Cederna JB; Winokur PL; Han JQ; Stapleton JT
    J Clin Microbiol; 1998 Jul; 36(7):2014-8. PubMed ID: 9650953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector.
    Urakawa T; Ferguson M; Minor PD; Cooper J; Sullivan M; Almond JW; Bishop DH
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1453-63. PubMed ID: 2543785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
    Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
    Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
    Emini EA; Hughes JV; Perlow DS; Boger J
    J Virol; 1985 Sep; 55(3):836-9. PubMed ID: 2991600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to nonstructural proteins of hepatitis A virus following infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of plant virus genes in animal cells: high-level synthesis of cowpea mosaic virus B-RNA-encoded proteins with baculovirus expression vectors.
    van Bokhoven H; Wellink J; Usmany M; Vlak JM; Goldbach R; van Kammen A
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2509-17. PubMed ID: 2254749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo transcriptional analysis of three baculovirus genes: evidence of homology between viral and host transcripts.
    Pham DQ; Sivasubramanian N
    Virology; 1992 Sep; 190(1):288-97. PubMed ID: 1529534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity.
    Karayiannis P; O'Rourke S; McGarvey MJ; Luther S; Waters J; Goldin R; Thomas HC
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2167-72. PubMed ID: 1654376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of single-chain urokinase-type plasminogen activator from insect cells.
    King LA; Kaur K; Mann SG; Lawrie AM; Steven J; Ogden JE
    Gene; 1991 Oct; 106(2):151-7. PubMed ID: 1834526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity of human and rabbit antisera to hepatitis A virus.
    Gauss-Müller V; Deinhardt F
    J Med Virol; 1988 Feb; 24(2):219-28. PubMed ID: 2832540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    Vaccine; 1992; 10 Suppl 1():S106-9. PubMed ID: 1335637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen.
    Crevat D; Crance JM; Chevrinais AM; Passagot J; Biziagos E; Somme G; Deloince R
    Arch Virol; 1990; 113(1-2):95-8. PubMed ID: 1696807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.